Proton Intelligence is a company focused on continuous biomarker monitoring, aiming to improve healthcare outcomes through advanced technology. Based in Vancouver, Canada, with research and development operations in Melbourne, Australia, Proton specializes in developing tools for continuous monitoring of electrolytes, particularly potassium. Its key product is a platform designed to monitor potassium levels in real-time, which is critical for managing patients with chronic kidney disease (CKD) and other related conditions.